Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know

finance.yahoo.com/news/cidara-therapeutics-over-100-heres-115700592.html

Key Points
-
Merck has announced plans to acquire Cidara Therapeutics for $9.2 billion, or $221.50 per share.
-
Representing a heavy premium to the biotech's prior trading price, the bid caused its shares to surge.
-
A bidding war isn't likely, but there are other profitable takeaways for…

This story appeared on finance.yahoo.com, 2025-11-20 11:57:00.
The Entire Business World on a Single Page. Free to Use →